Market Overview:
The global structural biology and molecular modeling techniques market is expected to grow at a CAGR of 10.8% from 2018 to 2030. The growth in this market can be attributed to the increasing demand for drug inheritance and drug gene applications, and the growing use of SaaS-based modeling solutions. However, the high cost of software licenses may restrain the growth of this market during the forecast period. On the basis of type, the global structural biology and molecular modeling techniques market is segmented into SaaS-based modeling, standalone modeling, and other types. The SaaS-based segment is expected to grow at a higher CAGR than other segments during the forecast period owing to its advantages such as low cost, easy deployment & upgradation, scalability & flexibility, and reduced TCO (total cost of ownership). On the basis of application,the global structural biology and molecular modeling techniquesmarket is divided into drug inheritance applicationsanddrug gene applications.
Product Definition:
Structural biology is a branch of biology that deals with the structure and function of the macromolecules that make up cells. Molecular modeling techniques are used to study the three-dimensional structures of these molecules. This information can be used to understand how they work and to design new drugs.
SaaS:
Software as a Service (SaaS) is a model that provides cloud-based solutions for various business functions such as data storage, email, marketing and sales automation. It also offers online applications that can be used directly from the internet browser without the need for any additional software or hardware. SaaS has been gaining popularity in recent years due to its cost effectiveness and ease of use.
Standalone Modeling:
Standalone modeling is a process of creating 3D models without any other application program in mind. It is used for various applications such as structural biology, molecular modeling, and others. Standalone software packages are gaining popularity among researchers due to its easy usage and flexibility to create models of almost every molecule including proteins, nucleic acids or small molecules.
The global standalone modeling.
Application Insights:
Drug inheritance accounted for the largest revenue share in 2016. Drug-target engagement is a key step in drug discovery and structural biology. Structural modeling of protein complexes has proven to be an effective approach for determining the binding modes of drugs within a target protein, which can subsequently lead to improved drug designs.
Structural models have also been used effectively during clinical trials to demonstrate efficacy over other treatment options by providing insights into molecular mechanisms that are not feasible through conventional methods such as computer simulation or bioinformatics analysis. The application of molecular modeling techniques has thus led to significant improvements in clinical trial design and proof-of-concept studies, thereby accelerating product adoption across various industries including pharmaceuticals and biotechnology companies involved in early phases of drug development.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a large number of players, high adoption rate for advanced technologies, and increasing R&D activities in this region. Moreover, rising healthcare expenditure coupled with supportive government initiatives is expected to drive growth during the forecast period. Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to factors such as improving healthcare infrastructure and growing awareness about structural biology & molecular modeling techniques among researchers from developing countries like India and China.
North America; Europe; Asia Pacific (APAC); Latin America (LAM); MEA; Rest of World or RoW).
Growth Factors:
- Increasing demand for novel drugs and therapies: The increasing demand for novel drugs and therapies is one of the key growth drivers for the structural biology and molecular modeling techniques market. This is because these techniques help in understanding the three-dimensional structure of biomolecules, which is essential for drug discovery and development.
- Growing focus on personalized medicine: The growing focus on personalized medicine is another key growth driver for the structural biology and molecular modeling techniques market. This is because these techniques help in understanding how individual patients respond to a particular drug or therapy, thereby helping in personalizing their treatment plans.
- Rising R&D expenditure by pharmaceutical companies: Pharmaceutical companies are increasingly allocating more funds towards R&D activities, with a view to developing new drugs and therapies. This is driving the demand for structural biology and molecular modeling techniques, as they are essential tools used during drug discovery & development process .
Scope Of The Report
Report Attributes
Report Details
Report Title
Structural Biology and Molecular Modeling Techniques Market Research Report
By Type
SaaS, Standalone Modeling, Other
By Application
Drug Inheritance, Drug Gene
By Companies
Acellera Ltd., Affymetrix, Agile Molecule, Agilent Technologies, Inc., Bioinformatic LLC, Biomax Informatics AG, Bruker Daltonics Inc., Chemical Computing Group, CLC bio, Dassault Systemes, Illumina
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
220
Number of Tables & Figures
154
Customization Available
Yes, the report can be customized as per your need.
Global Structural Biology and Molecular Modeling Techniques Market Report Segments:
The global Structural Biology and Molecular Modeling Techniques market is segmented on the basis of:
Types
SaaS, Standalone Modeling, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Drug Inheritance, Drug Gene
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Acellera Ltd.
- Affymetrix
- Agile Molecule
- Agilent Technologies, Inc.
- Bioinformatic LLC
- Biomax Informatics AG
- Bruker Daltonics Inc.
- Chemical Computing Group
- CLC bio
- Dassault Systemes
- Illumina
Highlights of The Structural Biology and Molecular Modeling Techniques Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- SaaS
- Standalone Modeling
- Other
- By Application:
- Drug Inheritance
- Drug Gene
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Structural Biology and Molecular Modeling Techniques Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Structural biology and molecular modeling techniques are used to study the structure and function of proteins, DNA, and other molecules. By understanding the structure of these molecules, scientists can better understand how they work and how to improve their performance.
Some of the key players operating in the structural biology and molecular modeling techniques market are Acellera Ltd., Affymetrix, Agile Molecule, Agilent Technologies, Inc., Bioinformatic LLC, Biomax Informatics AG, Bruker Daltonics Inc., Chemical Computing Group, CLC bio, Dassault Systemes, Illumina.
The structural biology and molecular modeling techniques market is expected to register a CAGR of 10.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Structural Biology and Molecular Modeling Techniques Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Structural Biology and Molecular Modeling Techniques Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Structural Biology and Molecular Modeling Techniques Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Structural Biology and Molecular Modeling Techniques Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Structural Biology and Molecular Modeling Techniques Market Size & Forecast, 2018-2028
4.5.1 Structural Biology and Molecular Modeling Techniques Market Size and Y-o-Y Growth
4.5.2 Structural Biology and Molecular Modeling Techniques Market Absolute $ Opportunity
Chapter 5 Global Structural Biology and Molecular Modeling Techniques Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Structural Biology and Molecular Modeling Techniques Market Size Forecast by Type
5.2.1 SaaS
5.2.2 Standalone Modeling
5.2.3 Other
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Structural Biology and Molecular Modeling Techniques Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Structural Biology and Molecular Modeling Techniques Market Size Forecast by Applications
6.2.1 Drug Inheritance
6.2.2 Drug Gene
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Structural Biology and Molecular Modeling Techniques Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Structural Biology and Molecular Modeling Techniques Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Structural Biology and Molecular Modeling Techniques Analysis and Forecast
9.1 Introduction
9.2 North America Structural Biology and Molecular Modeling Techniques Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Structural Biology and Molecular Modeling Techniques Market Size Forecast by Type
9.6.1 SaaS
9.6.2 Standalone Modeling
9.6.3 Other
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Structural Biology and Molecular Modeling Techniques Market Size Forecast by Applications
9.10.1 Drug Inheritance
9.10.2 Drug Gene
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Structural Biology and Molecular Modeling Techniques Analysis and Forecast
10.1 Introduction
10.2 Europe Structural Biology and Molecular Modeling Techniques Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Structural Biology and Molecular Modeling Techniques Market Size Forecast by Type
10.6.1 SaaS
10.6.2 Standalone Modeling
10.6.3 Other
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Structural Biology and Molecular Modeling Techniques Market Size Forecast by Applications
10.10.1 Drug Inheritance
10.10.2 Drug Gene
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Structural Biology and Molecular Modeling Techniques Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Structural Biology and Molecular Modeling Techniques Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Structural Biology and Molecular Modeling Techniques Market Size Forecast by Type
11.6.1 SaaS
11.6.2 Standalone Modeling
11.6.3 Other
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Structural Biology and Molecular Modeling Techniques Market Size Forecast by Applications
11.10.1 Drug Inheritance
11.10.2 Drug Gene
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Structural Biology and Molecular Modeling Techniques Analysis and Forecast
12.1 Introduction
12.2 Latin America Structural Biology and Molecular Modeling Techniques Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Structural Biology and Molecular Modeling Techniques Market Size Forecast by Type
12.6.1 SaaS
12.6.2 Standalone Modeling
12.6.3 Other
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Structural Biology and Molecular Modeling Techniques Market Size Forecast by Applications
12.10.1 Drug Inheritance
12.10.2 Drug Gene
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Structural Biology and Molecular Modeling Techniques Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Structural Biology and Molecular Modeling Techniques Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Structural Biology and Molecular Modeling Techniques Market Size Forecast by Type
13.6.1 SaaS
13.6.2 Standalone Modeling
13.6.3 Other
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Structural Biology and Molecular Modeling Techniques Market Size Forecast by Applications
13.10.1 Drug Inheritance
13.10.2 Drug Gene
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Structural Biology and Molecular Modeling Techniques Market: Competitive Dashboard
14.2 Global Structural Biology and Molecular Modeling Techniques Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Acellera Ltd.
14.3.2 Affymetrix
14.3.3 Agile Molecule
14.3.4 Agilent Technologies, Inc.
14.3.5 Bioinformatic LLC
14.3.6 Biomax Informatics AG
14.3.7 Bruker Daltonics Inc.
14.3.8 Chemical Computing Group
14.3.9 CLC bio
14.3.10 Dassault Systemes
14.3.11 Illumina
